{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:00:43Z","timestamp":1785261643936,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.diagmicrobio.2010.02.026","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T07:03:08Z","timestamp":1276239788000},"page":"228-233","source":"Crossref","is-referenced-by-count":61,"title":["Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia"],"prefix":"10.1016","volume":"67","author":[{"given":"Elizabeth A.","family":"Neuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Casabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reichley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy S.","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2010.02.026_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1469-0691.2007.01720.x","article-title":"A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I\u2013V","volume":"13","author":"Boye","year":"2007","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib3","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/507918","article-title":"Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus","volume":"27","author":"Davis","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein","volume":"190","author":"Fowler","year":"2004","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2010.02.026_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/JCM.00397-08","article-title":"Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center","volume":"47","author":"Ganga","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2010.02.026_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/archinte.167.17.1861","article-title":"Persistent Staphylococcus aureus bacteremia","volume":"167","author":"Hawkins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib10","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch of Intern Med"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.130.4.947","article-title":"Predictors of mortality for methicillin-resistant Staphylococcus aureus heath-care-associated pneumonia","volume":"130","author":"Jeffres","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/00365540310016682","article-title":"Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse","volume":"35","author":"Johnson","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1086\/432472","article-title":"Time to positivity in Staphylococcus aureus bacteremia: possible correlation with source and outcome of infection","volume":"41","author":"Khatib","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome","volume":"38","author":"Khatib","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib15","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/313461","article-title":"Involvement of Panton\u2013Valentine leukocidin producing Staphylococcus aureus in primary skin infections and pneumonia","volume":"29","author":"Lina","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2010.02.026_bib16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.clinthera.2006.08.003","article-title":"Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 \u03bcg\/ml and risk factors, costs, and outcomes in inpatients undergoing hemodialysis","volume":"28","author":"Maclayton","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/518451","article-title":"Point: vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus","volume":"44","author":"Mohr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib18","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","article-title":"Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy","volume":"38","author":"Moise-Broder","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.diagmicrobio.2010.02.026_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"22","key":"10.1016\/j.diagmicrobio.2010.02.026_bib20","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib21","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2010.02.026_bib22","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00365540510038488","article-title":"The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteremia","volume":"37","author":"Siegman-Igra","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2010.02.026_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2010.02.026_bib25","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/491714","article-title":"The role of vancomycin in the treatment paradigm","volume":"42","author":"Stevens","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889310000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889310000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T06:56:31Z","timestamp":1544424991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889310000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0732889310000829"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.02.026","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}